Benjamin M Heyman

12PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiovascular medicine and haematology not elsewhere classifiedAutoimmunityRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 22, 2026
Comparison of Venetoclax-Based Treatments for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia: A Single-Center Real-World Experience.

|Jun 27, 2025
Venetoclax Consolidation After Bruton Tyrosine Kinase Inhibitor Treatment for Patients With Chronic Lymphocytic Leukemia.

Benjamin Heyman, Michael Choi, Thomas J Kipps

|Mar 28, 2025
Updates on the Treatment of Richter's Syndrome, Including Novel Combination Approaches.

Tanim Jain, Benjamin Heyman

|Feb 26, 2025
Antibody Therapy for Patients with Lymphoid Malignancies: Past and Present.

Jacob Naman, Nirja Shah, Benjamin M Heyman

|Mar 04, 2024
A + AVD for Treatment of Hodgkin Lymphoma Variant of Richter's Transformation.

Benjamin Heyman, Michael Choi, Thomas J Kipps

|Feb 26, 2024
Novel BRAF N581S mutation in mantle cell lymphoma.

Nisha Hariharan, Davsheen Bedi, Michael Y Choi

Pageof 2

Frequent Collaborators

1 joint publications

Jacob Naman